日前，AVEA的联合创始人兼首席执行官 Duri Granziol 受到新华社采访，共同探讨中国长寿健康领域的发展。Duri直言：“中国对我们来说是一个很大的市场，我们已经通过抖音和天猫上的跨境电商扩展到中国。同时我们也在拓展小红书和微信的渠道，未来将继续加大中国市场的投入，让更多的人能享受到前沿的抗衰科技。”
纵观人类历史，人们一直在追求更长寿、更健康的生活。随着全球人口老龄化加剧，健康长寿行业近年来发展迅速，致力于延长人类健康寿命，提高随着年龄增长的生活质量。
这个新兴产业涵盖了生物技术、制药和医疗保健等多个领域，旨在对抗衰老和与年龄相关的疾病。对于该领域的投资者来说，中国市场拥有大量难以抗拒的商机。
新加坡国立大学健康长寿中心主任布莱恩·肯尼迪在瑞士山城格施塔德举行的长寿投资者大会上接受采访时表示，中国将成为健康长寿膳食补充剂的主要市场。
这来自传统中医的观点，其本质是预防性的。他说，中医的整个概念都是基于保持人们的健康。
“中国是一个巨大的长寿健康市场。如果你看看膳食补充剂，它肯定是最大的市场之一”，这位健康专家说，并补充说，中国的健康长寿市场将继续增长。
2023年，中国60岁及以上人口达到2.97亿，占总人口的21.1%。
长寿投资者会议联合创始人马克·P·伯内格（Marc P. Bernegger）也有类似的看法。他告诉新华社，中国是这个蓬勃发展的行业的关键焦点。
“中国文化一直与长寿这个词联系在一起”，他说。
总部位于瑞士的科技抗衰补剂公司AVEA也看到了中国市场巨大的增长潜力。AVEA专注于长寿抗衰领域，产品包括断糖控体胶囊、胶原蛋白前体、细胞修复等抗衰老的产品。
“中国对我们来说是一个很大的市场，我们已经通过抖音和天猫上的跨境电商扩展到中国。我们加入了小红书，并拥有了自己的微信频道，我们的业务得到了进一步扩展。” AVEA 联合创始人兼首席执行官Duri杜里·格兰齐奥尔在谈到中国商业和社交媒体平台时告诉新华社。
他说，在中国市场发展需要采取不同的方法，与消费者创建信任非常重要。这也是为什么该公司已经与中国社交媒体KOL合作并开始进行直播的原因。
Duri格兰齐奥尔说，中国拥有一个惊人的市场，中国消费者要求真正的品质产品，并补充说，瑞士作为质量领域的领导者以及制造和研究基地，致力于提供高质量的产品。
以下是新华社的报道全文：
by Martina Fuchs
GSTAAD, Switzerland, Oct. 6 (Xinhua)
Throughout human history, people have aimed for longer, healthier lives. As the global population is aging, the longevity industry, a rapidly growing sector focused on extending the human lifespan and improving the quality of life as people age, has experienced rapid growth in recent years.
The nascent industry encompasses a wide range of fields, including biotechnology, pharmaceuticals, and healthcare, all aimed at combating aging and age-related diseases. For investors in this field, China has abundant business opportunities that are irresistible.
China is set to become a leading market for longevity and supplements prolonging the lifespan and health span of its population, Brian Kennedy, director of the Centre for Healthy Longevity at the National University of Singapore said in an interview during the Longevity Investors Conference in the Swiss mountain town of Gstaad.
This comes from the traditional Chinese medicine (TCM) view, which is preventative in nature. The whole concept of TCM is based on keeping people healthy, he said.
"China is already a large market for longevity. If you look at supplements, it's certainly one of the biggest markets," the health expert said, adding that the market for longevity will continue to grow in China.
In 2023, people aged 60 and above in China amounted to 297 million, accounting for 21.1 percent of its total population.
Marc P. Bernegger, co-founder of the Longevity Investors Conference, had a similar view. He told Xinhua that China is a key focus for the booming industry.
"Chinese culture has always been affiliated with the term longevity," he said.
People in Europe get treated as soon as they are sick, but in China, people have a completely different approach, and that's why China has an obvious market when it comes to longevity-related businesses, he explained.
Swiss-based longevity supplement startup Avea also sees huge growth potential in China where people want to have solutions to staying healthy longer.
The company sells longevity and vitality supplement products ranging from stabilizers for blood sugar levels, collagen activators, cell primers, and antioxidant boosters, to rejuvenation products that reduce signs of aging.
"China is a big market for us, we've expanded into China through cross-border e-commerce on Douyin and Tmall. We have expanded further since we are on the Little Red Book, we are on Weixin and have our own Weixin channel," Duri Granziol, Avea's co-founder and CEO, told Xinhua, referring to Chinese commerce and social media platforms.
Thriving in the Chinese market requires a different approach due to the importance of building trust with consumers, he said. That's why the company has already collaborated with Chinese social media influencers and started to conduct live streams.
China has an amazing market and Chinese consumers demand actual quality, Granziol said, adding that Switzerland, as a leader in quality and as a manufacturing and research base, could provide high-quality products.
原文来源：
https://xhnewsapi.xinhuaxmt.com/share/news_pc?id=1005012708384768&showType=3008&utdId=7f303d0bdf4449078bb86599577dc6dd&version=4.0.5
免责声明：市场有风险，选择需谨慎！此文仅供参考，不作买卖依据。
